Literature DB >> 10205469

The effect of a structured neonatal resuscitation program on delivery room practices.

C A Ryan1, L M Clark, A Malone, S Ahmed.   

Abstract

PURPOSE: This study evaluated the introduction of the Neonatal Resuscitation Program (NRP) of the American Academy of Pediatrics and the American Heart Association into the delivery room of an Irish maternity hospital.
DESIGN: Prospective, controlled observational study of 51 deliveries before and 51 deliveries following the training of delivery room personnel in the NRP. SAMPLE: Participants were 33 nurse-midwives and 11 pediatric resident physicians. MAIN OUTCOME VARIABLE: Evaluation of postdelivery, newborn resuscitation practices.
RESULTS: The introduction of the NRP was associated with significant improvements in delivery room preparation, in the evaluation and management of the newborn infant, and in thermal protection at birth. Although there was a trend to use more free-flow oxygen following the introduction of the NRP, this was not statistically significant. Bag and mask ventilation was also used more frequently following NRP training. However, there were no significant differences in the use of endotracheal intubation, chest compressions, and medications. Fifteen of the 51 infants became hypothermic prior to the introduction of the NRP; none of the infants developed hypothermia in the post-NRP part of the study.

Entities:  

Mesh:

Year:  1999        PMID: 10205469     DOI: 10.1891/0730-0832.18.1.25

Source DB:  PubMed          Journal:  Neonatal Netw        ISSN: 0730-0832


  2 in total

Review 1.  Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions.

Authors:  Fernando C Barros; Zulfiqar Ahmed Bhutta; Maneesh Batra; Thomas N Hansen; Cesar G Victora; Craig E Rubens
Journal:  BMC Pregnancy Childbirth       Date:  2010-02-23       Impact factor: 3.007

2.  Speaking up and sharing information improves trainee neonatal resuscitations.

Authors:  Lakshmi I Katakam; Amber W Trickey; Eric J Thomas
Journal:  J Patient Saf       Date:  2012-12       Impact factor: 2.844

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.